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Gene  expression  regulation  is a critical  question  in  host-pathogen  interactions,  and  RNAs  act  as  key
players  in  this  process.  In  this  review,  we focus  on  the  mammalian  RNA  response  to  bacterial  infection,
with  a special  interest  on microRNAs  and  long  non-coding  RNAs.  We  discuss  the  role  of cellular  miRNAs  in
immunity,  the implication  of  circulating  miRNAs  as  well  as  the  inﬂuence  of  the  microbiome  on  the miRNA
response.  We  also  review  how  pathogens  counteract  the  host  miRNA  expression.  Interestingly,  bacterialeywords:
ost-pathogen
acteria
icroRNA
ncRNA
non-coding  RNAs  regulate  host  gene  expression  and  conversely  eukaryotic  miRNAs  may  regulate  bacterial
gene  expression.  Overall,  the  characterization  of  RNA  regulatory  networks  represents  an  emerging  theme
in the  ﬁeld  of  host  pathogen  interactions.
© 2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).egulatory network
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/).1. Introduction
During infection, both bacteria and host undergo signiﬁcant
changes of environmental or physiological conditions, to whichRNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
they can adapt or react. Extra- and intra-cellular pathogenic bac-
teria can adjust their metabolism and trigger the expression of
virulence genes, which allow them to beneﬁt from their host
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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esources. Likewise, infected organisms are capable of sensing
he intrusion by bacterial pathogens, and react by triggering
nnate or adaptive immune defences. The complex interplay of
ctions/counter-actions occurring between a bacterial invader and
n infected organism is referred to as host-pathogen crosstalk. This
rosstalk, on the bacterial or on the host side, involves the coordi-
ated regulation of gene expression programmes with the phase of
nfection, controlled at the transcriptional or post-transcriptional
evel. For instance, the transcriptome of cells infected by intra-
ellular bacteria is completely reshaped, as a result of pathogen
etection by speciﬁc cellular sensors (reviewed in [1]), and of spe-
iﬁc modulation by bacterial effectors (reviewed in [2]).
RNA itself represents a key regulatory molecule. Indeed, its
hysicochemical properties make non-coding RNAs (ncRNA) ver-
atile tools for interfering with gene expression, independently of
he coding function played by messenger RNAs (mRNA). Recog-
ition by base-pairing allows one single ncRNA to bind multiple
argets, and thereby to regulate several pathways simultaneously
3]. Conversely, a single gene can be regulated by a variety of ncR-
As, allowing its control in a broad range of conditions.
Over the past 10 years, mechanisms and effects of RNA-
ediated regulation on gene expression have been broadly
nvestigated in prokaryotes and eukaryotes. Various examples
f RNA-mediated regulation in pathogenic bacteria have been
ecently reviewed [4–7]. Here, we focus on regulation involving
ammalian ncRNAs during host-pathogen interaction, and more
recisely on two classes of ncRNAs: microRNAs (miRNA) and long
on-coding RNAs (lncRNA). These ncRNAs act at the transcriptional
nd post-transcriptional levels in the control of host gene expres-
ion, and are themselves the object of regulations.
The name lncRNA is given to a class of eukaryotic ncRNAs of
ore than 200 nucleotides transcribed by RNA polymerase II (PolII).
ike messenger RNAs, most of these transcripts are poly-adenylated
nd spliced [8]. Even though the ﬁrst mammalian lncRNA, XIST (X-
nactive speciﬁc transcript), was discovered 25 years ago [9,10], the
dentiﬁcation and functional characterization of these noncoding
ranscripts remain an emerging ﬁeld. Several lncRNAs have been
hown to regulate gene expression at the level of transcription or
ranslation (for reviews see [11–13]). The expression of most lncR-
As is tissue-speciﬁc, or restricted to precise developmental stages;
n addition, some lncRNAs are involved in host response against
iral infection (reviewed in [8]). Very recent studies show that lncR-
As are also involved in the response against pathogenic bacteria,
hich we will describe below.
miRNAs are a class of PolII-dependent transcripts that are pro-
essed into a short mature form (21–24 nucleotides). To date, more
han 35,000 distinct microRNAs have been described in 223 organ-
sms (miRBase, release 21), and are predicted to regulate 60% of
uman protein-coding genes [14]. They are involved in multiple
rocesses including cell proliferation, differentiation, inﬂamma-
ion, etc. [15–17]. After being transcribed, the canonical biogenesis
f miRNAs involves the processing of a hairpin precursor into a
ouble stranded duplex by two major nucleases, Drosha and Dicer
reviewed in [15]). After export to the cytoplasm, one strand of the
uplex is loaded into an effector complex called RISC (RNA-induced
ilencing complex), which drives the microRNA to its target mRNA
nd mediates its function, usually by promoting RNA degradation
r impeding translation, even though a few activation mechanisms
ave also been described [18]. In addition to transcription, the
mount of available functional miRNAs in the cytoplasm can be
egulated via their sequestration by binding proteins, or by a class
f ncRNAs called miRNA sponges. Their deregulation was  shown inPlease cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
ome instances to promote diseases, such as cancer, auto-immunity
r cardiovascular disorders [19–21].
To counteract bacterial infection, host cells adjust their gene
xpression programme, among other pathways by using miRNA PRESS
mental Biology xxx (2016) xxx–xxx
and lncRNA as regulatory molecules. Reciprocally, pathogens can
escape host defence mechanisms using a variety of strategies, and
in particular by targeting miRNA-mediated regulation. Here, we
review the role and subversion of mammalian ncRNAs during host
pathogen crosstalk.
2. Host cell microRNA response to bacterial infection
2.1. Discovery of microRNA response against pathogens
In 2006, the ﬁrst studies describing a host miRNA response to
challenges with bacterial components were published. Recogni-
tion of Pseudomonas syringae ﬂagellin by Arabidopsis thaliana was
shown to induce the expression of miR-393a and the subsequent
inhibition of the expression of three F-box auxin receptors. This, in
turn, decreases signalling by auxin, a plant hormone that modulates
immune response, and limits bacterial spread within tissue [22]. In
human monocytes, the involvement of miRNAs in innate immune
response to lipopolysaccharide (LPS, the major component of the
outer membrane of Gram negative bacteria) stimulation was  inves-
tigated. This work has led to the characterization of miR-146 as an
anti-inﬂammatory miRNA [23].
Following these two studies, the miRNA response upon bacterial
infection in mammals has been widely investigated. Infection by
different pathogens leads to the expression of speciﬁc microRNA
sets that are regulated in a time-dependent manner [24]. Among
them, miR-155, miR-146, let-7 and miR-29 play important roles in
the host cells response to bacteria [25–28]. These miRNAs regulate
the immune responses in order to clear bacterial infection, while
preserving the organism from deleterious effects of inﬂammation.
They will be described below.
A recent analysis of the miRNAs expressed in dendritic cells
in response to six different bacteria has revealed a core tempo-
ral response to infection comprising 49 miRNAs that may  play an
essential role in response to infection, in addition to subtle variabil-
ity for each bacterium, that can be considered as a speciﬁc signature
[29] (Fig. 1a). Moreover, infection can induce a switch in the rel-
ative abundance of mature miRNAs deriving from the 5′ and 3′
arms of the precursor (a process described as “arm-switching”, [30],
Fig. 1b), and changes the proportion of miRNA variants (isomiRs,
Fig. 1c). Such variability in miRNA identity is thought to affect their
regulatory potential, but this aspect deserves more investigations
[29].
2.2. Key microRNAs involved in immunity
Upon infection, miR-155 and miR-146 are two  miRNAs induced
by the NF-B pathway through pattern recognition receptors (PRR)
sensing of pathogen motifs, in particular LPS (Fig. 2a). These miRNAs
regulate distinct sets of genes [23,31].
Expression of miR-146 is induced by sub-inﬂammatory levels
of NF-B activity. It acts as an anti-inﬂammatory regulator, by
targeting TRAF6 (TNF Receptor-associated factor 6) and IRAK1 (IL-
1R-associated kinase 1), which are involved in the NF-B pathway
(Fig. 2b), thus promoting tolerance to low doses of LPS [23,31].
This desensitized state is necessary to protect the organism against
septic shock. A tolerance state is also crucial during the postna-
tal establishment of the intestinal microbiota in the newborn gut,
where miR-146 prevents inappropriate inﬂammation (for a review,
[32]).
In contrast, miR-155 is induced by higher doses of LPS, at lev-RNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
els which result in pro-inﬂammatory NF-B activity, as well as by
TNF- and interferon , via TAB2 [31,33,34]. miR-155 is known to
amplify the expression of pro-inﬂammatory factors, thereby acting
in defence against pathogens, and also to exert negative feedback
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Fig. 1. Host microRNA variation upon infection.
Upon pathogen exposure, miRNA variability occurs at different levels. (a) The abundance of miRNAs is modiﬁed to face infection, and miRNAs are up- or down-regulated
early  or late in response to pathogens, leading to the expression of a core temporal response common to all pathogens, as well as a speciﬁc response; (b) The choice of the
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s  observed (inspired from [29]).
n the immune system, thus protecting the host from potentially
amaging overreaction [31]. The involvement of this miRNA in
he pro-inﬂammatory response has been thoroughly investigated;
mong others, miR-155 targets SHIP1 (Fig. 2c), a negative reg-
lator of the NF-B pathway [35,36], and SOCS1 (suppressor of
ytokine signalling 1), an effector involved in the homeostasis of
reg cells [37]. This in turn, stimulates the expression of the pro-
nﬂammatory cytokines TNF-, IL-6, IL-1, IL-8 and IL-12, while
t reduces the expression of the anti-inﬂammatory cytokine IL-10
38,39]. A complex interplay occurs upon infection, as IL-10 itself
an reduce miR-155 expression in response to LPS [40]. miR-155
lso increases TNF- production upon LPS stimulation (Fig. 2d),
robably by stabilizing the transcript or by promoting its trans-
ation when targeting the expression of proteins that binds the
ranscript 3′-UTR [34]. Multiple miR-155 targets are also involved
n T helper cell development, or promote autophagy by inhibit-
ng the mTOR pathway [41–43]. In line with these data, miR-155
s essential for an efﬁcient immune response to several bacterial
athogens. Indeed, miR-155 null mice show a slower clearance
pon Citrobacter rodentium infection [44], as well as an impaired
D8+ T-cell response to Listeria monocytogenes [45]. Moreover,
iR-155 is essential in the vaccination process against Salmonella
yphimurium [46]. However, this miRNA has also been shown to
epress genes such as NIK, IKK and TAB2, which encode proteins
nvolved in the inﬂammatory pathway (Fig. 2e); accordingly, it
s proposed that miR-155 could act as a limiter of inﬂammation
31,34,47]. Interestingly, miR-155 expression is also stimulated by
he intracellular NOD2 receptor (Fig. 2f). In tolerant macrophages,Please cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
here miR-146 prevents inﬂammation, stimulation of NOD2 can
estore the NF-B pathway activation, as well as the feedback con-
rol by miR-155 [31]. called “arm-switching”; (c) Generation of isomiRs in addition to canonical miRNAs
Another well-described miRNA family is the let-7 family,
which targets different genes involved in immunity. This family
is repressed upon infection by various pathogens as well as by
exposure to LPS [48–52]. Indeed, NF-B activation induces Lin-
28B expression, a protein that blocks let-7 maturation [53]. In
addition, various studies have highlighted an active repression
of these miRNAs mediated by the bacteria themselves [54–56].
Several targets have been described for let-7 family miRNAs. let-
7b targets the TLR4 transcript and as a consequence, bacterial
infection-mediated let-7b repression promotes TLR sensing and
subsequent NF-B activation [51]. let-7a and let-7d target IL-6
and IL-10 transcripts; their down-regulation could contribute to
maintaining a balanced immune response upon bacterial expo-
sure [50]. let-7c targets the mTOR pathway, thus modulating T-cell
activity [57]. let-7i reduces expression of SNAP23 protein, which is
involved in exosome release, a process that is part of the antimicro-
bial response [52]. The abundant let-7f targets the deubiquinating
enzyme A20, an inhibitor of the NF-B pathway [56]; its downreg-
ulation by Mycobacterium tuberculosis favours bacterial survival in
macrophages [56].
In murine leucocytes, miR-29 was shown to repress inter-
feron (IFN)- expression, and thereby control immune responses
to intracellular bacteria [58]. During infection of natural killer cells,
CD4+ and CD8+ T-cells, by Listeria monocytogenes or Mycobacterium
bovis bacillus Calmette-Guérin (BCG), miR-29 expression is down-
regulated, thereby facilitating IFN- production and subsequent
bacterial clearance. Strikingly, miR-29 is one of the microRNAs trig-
gered during infection of macrophages by L. monocytogenes [59].RNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
Even though the effect of this up-regulation is unknown, it sug-
gests that infection can differentially control the expression of
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Fig. 2. Mammalian non-coding RNAs at work during host-pathogen crosstalk.
A  complex interplay of microRNA and lncRNA occurs during bacterial infection. miRNAs miR-155 and −146 are induced by PRRs in a NF-B-dependent pathway (a), and
regulate  different sets of transcripts (b,c,d,e) thus promoting or dampening inﬂammation. miR-155 is also induced by NOD2 cytoplasmic receptors (f). Exosomal transfer
of  miRNAs allows cell-to-cell communication (g) and extracellular miRNAs might regulate bacterial gene expression (h). To subvert host defences, bacteria can perturb
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esponse, as they affect chromatin structure (l), thus leading to expression of antim
hus  preventing its DNA binding activity (m).
iRNAs, and as a consequence, that of their targets, depending on
he affected cell type.
Altogether, these examples provide evidence that miRNAs act
s major components of regulatory networks in immune pathways.
heir production is temporally regulated in a dose-dependent man-
er, resulting in the induction or dampening of immunity, and
llowing a rapid and potent response against pathogens.
.3. Circulating microRNAs during infection
Aside from their activity inside the cell, miRNAs are power-
ul molecules for cell-to-cell communication. Indeed, miRNAs are
ound in many body ﬂuids, including plasma, saliva, tears, urine,
mniotic ﬂuid, colostrum, breast milk, stool, etc. [60,61]. Exosomes,
hich are circulating small lipid vesicles formed from cell plasma
embranes, can transport molecules. Exosomal transfer of miRNAs
s a powerful mechanism to expand the host response to bacte-
ial infection. Recently, it has been shown that upon LPS exposure,
iR-155 and miR-146a are released from bone marrow-derived
endritic cells (BMDCs) within exosomes and are successfullyPlease cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
ransferred to recipient cells [62] (Fig. 2 g). Upon uptake, miRNAs
egulate gene expression and reprogram the response of BMDCs to
PS. The authors propose several hypotheses; one of them is that
iRNA release in exosomes could be a dynamically regulated pro-y interfere with host gene expression (k). lncRNAs are key players in inﬂammatory
ial molecules. They can also hamper inﬂammation, by sequestering RelA/p65 and
cess where the ratio of miR-155/miR-146a changes over time, thus
enhancing the inﬂammation upon infection, and then dampening
it during recovery.
Exosomal miRNAs could give rise to therapeutic perspectives:
miR-146-containing exosomes could be used to treat inﬂamma-
tory diseases, while miR-155-containing exosomes could be used
as an adjuvant to improve vaccine efﬁcacy, or to ﬁght infections
as it has been proposed for Helicobacter pylori [63]. In addition,
these circulating miRNAs are now used or proposed as biomarkers
in diagnostic tools for diseases, including sepsis and tuberculosis
[64–67]. For instance, the signature pattern of circulating miRNAs
in the blood of mice shows a differential response to either LPS
[68] or lipoteichoic acids (LTA, a major constituent of the cell wall
of Gram positive bacteria) [69]. Nine speciﬁc circulating miRNAs
were also identiﬁed in the serum of mice infected by Staphylococcus
aureus,  but not by Escherichia coli [70].
Finally, a recent article relates the in vitro ability of miRNAs
isolated from faeces to penetrate inside E. coli and Fusobacterium
nucleatum and to regulate the expression of bacterial genes in a
sequence-speciﬁc manner (Fig. 2 h). Whether this phenomenonRNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
occurs in vivo remains to be determined, nevertheless this discov-
ery opens new perspectives about the possible roles of miRNAs in
host-pathogen interaction [60].
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.4. Inﬂuence of commensals on the microRNA response to a
ood-borne pathogen
The resident intestinal microbiota has been long known to play
 major role in intestinal homeostasis by shaping the gut tran-
criptome. An increasing number of studies indicate that miRNAs
re participating in this host/commensal crosstalk, and largely
ontribute to regulatory networks controlling tissue integrity,
mmunity and metabolism (reviewed in [71]). For instance, miRNA
xpression inﬂuences the microbiota composition as well as host
esistance to dextran sulphate sodium (DSS)-induced colitis [60].
he presence and nature of the intestinal ﬂora can also tune infec-
ion by a bacterial pathogen such as L. monocytogenes, as well as
he host mRNA and miRNA responses [72,73]. Oral pre-treatment
ith lactobacilli of otherwise germ-free mice signiﬁcantly reduces
heir sensitivity to orally-acquired listeriosis and reshapes host
ene expression, notably of genes coding for proteins in the
nterferon pathway. Furthermore, lactobacilli oral pre-treatment
an counteract the down-regulation of miR-192, miR-200b, and
iR-215 induced by L. monocytogenes infection [73]. A study com-
aring the intestinal response to Listeria infection in conventional
ersus germ-free mice has additionally highlighted ﬁve microR-
As down-regulated by Listeria infection only in the presence
f the microbiota, and not affected in germ-free mice (miR-143,
iR-148a, miR-200b, miR-200c, and miR-378), suggesting that
ommensals can prime the host microRNA response to infection
72]. This work has also outlined a network of putative regula-
ory interactions between host microRNAs and their target mRNAs
mpacted by infection, paving the way to future mechanistic stud-
es aiming at understanding how these microRNAs modulate the
ntestinal response to infection.
. Subversion of microRNA pathways by bacterial
athogens
.1. Manipulation of cell physiology
During infection, bacteria can interfere with many cellular pro-
esses using effector molecules [74]. In particular, by modulating
he production of miRNAs, they manipulate their host cell phys-
ology and defences, with favourable consequences for pathogen
urvival (Table 1). For example, Helicobacter pylori induces the
ncrease of miR-1289, which represses HK,  a component of the
astric H+/K+ ATPase. This results in a transient decrease of gas-
ric acidity that promotes H. pylori colonization. The mechanism
s dependent on CagA, a bacterial effector known to activate the
F-B pathway [75]. H. pylori also interferes with autophagy by
nducing the expression of miR-30b, which targets BECN1 and
TG12 transcripts that encode proteins involved in the formation
nd maturation of autophagosomes [76].
Another example of this subversion is the reduction of
ost SUMOylation by Salmonella,  via the stimulation of two
iR-30 family miRNAs, miR-30c and miR-30e, and subsequent
own-regulation of their target Ubc9, the only cellular E2 SUMO-
onjugating enzyme [77]. The mechanism used by Salmonella to
p-regulate these microRNAs is unknown.
The cell cycle is an important target for pathogens, as it inﬂu-
nces their ability to survive and/or proliferate. The perturbation of
peciﬁc miRNAs is used to this end by Salmonella.  Indeed, by inhibit-
ng the production of the transcriptional factor E2F1, Salmonella
educes the expression of the miR-15 family [78]. This inducesPlease cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
he de-repression of cyclin D1 and thus promotes the G1/S cell
ycle transition, which is favouring bacterial intracellular repli-
ation (Fig. 3a). A similar mechanism has been described for H.
ylori, which down-regulates miR-372 and miR-373 expressionBy inhibiting different sets of miRNAs, Salmonella (a) and Helicobacter pylori (b)
perturb the host cell cycle, thus promoting their survival and proliferation.
in a CagA-dependent manner. This induces a cell cycle arrest at
the G1/S transition and inhibits renewal of the gastric epithe-
lium (Fig. 3b), a major host defence mechanism against bacterial
infection [79]. CagA also promotes the expression of miR-584
and miR-1290, which target FOXA1, a negative regulator of the
epithelial-mesenchymal transition [80]. In addition to short-term,
acute bacterial infections, pathogens also induce long-term effects,
as it is exempliﬁed by H. pylori in carcinogenesis. The investigation
of the roles of miRNAs in this process has revealed that this bac-
terium induces the expression of miR-21 and miR-222, two miRNAs
that target the tumor suppressor RECK [81,82].
3.2. Effect on immune response
Bacteria deploy diverse mechanisms to counteract macrophage
recruitment and/or activation, as well as induction of pro-
inﬂammatory factors. For instance, secreted effectors from
Salmonella stimulate, via the p53 signalling pathway, the expres-
sion of miR-128, which targets the macrophage colony-stimulating
factor (M-CSF) and thereby leads to impaired M-CSF–mediated
macrophage recruitment [83]. Likewise, M. tuberculosis can limit
macrophage response to IFN- by up-regulating miR-132 and miR-
26a [84]. These two miRNAs down-regulate the transcriptional
coactivator p300, a component of the IFN- signalling cascade.
Mycobacterium also reduces the production of TNF-, a potent
mediator of macrophage activation and bacterial clearance, by
regulating the abundance of miR-125b, miR-155 and miR-99b
[85,86] (Fig. 2i). This leads to the destabilization of TNF- mRNA
transcripts and an increase of SHIP1 production, subsequently
reducing the production of TNF-. In addition, the secreted effec-
tor from M. tuberculosis ESAT-6 down-regulates the expression
of let-7f in macrophages, which leads to increased expression of
the deubiquitinating enzyme A20, a negative regulator of the NF-
B pathway [56]. M.  tuberculosis ESAT-6 also stimulates miR-155
expression in macrophages, thus repressing BACH1 and SHIP1.
This, in turn, induces the expression of the heme oxygenase 1, and
activates the serine/threonine kinase AKT, which respectively pro-
mote bacterial dormancy and survival [87] (Fig. 2j). However, theRNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
ESAT-6-dependent induction of miR-155 also induces macrophage
apoptosis by down regulating SOCS1 protein [88] and targeting
Rheb [43] which is deleterious for the pathogen.
ARTICLE IN PRESSG ModelYSCDB-2061; No. of Pages 9
6 M. Duval et al. / Seminars in Cell & Developmental Biology xxx (2016) xxx–xxx
Table 1
Bacteria subvert host defences by modulating microRNA expression.
Bacteria miRNA Up/down-regulation Targeted cellular function Cell lines References
Helicobacter pylori miR-1289 up gastric acidity AGS [76]
miR-30b up autophagy AGS and human gastric
tissues
[77]
miR-372 and miR-373 down cell cycle AGS [80]
miR-584 and miR-1290 up epithelial-mesenchymal transition AGS, SGC7901 and 293T [81]
miR-21 and miR-222 up carcinogenesis AGS, SGC7901, MKN28,
MKN45, HGC-27,
BGC-823, GES-1
[82,83]
Salmonella spp. miR-30c and miR-30e up SUMOylation HCT-8, HeLa, J774A.2 [78]
miR-15 family down cell cycle HeLa, HT-29, RAW 264.7 [79]
miR-128 up macrophage recruitment HT29 [84]
Mycobacterium
tuberculosis
miR-132, miR-26a up macrophage response to IFN- hMDM [85]
miR-125b, miR-99b, miR-155 up, up, down production of TNF- hMDM, mDC [86,87]
let-7f down NF-B pathway RAW264.7, BMDM,  and
hMDM
[57]
miR-155 up NF-B pathway RAW264.7 and BMDM [88]
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eacteria manipulate the expression of various miRNAs in order to modulate cellular
GC-27,  BGC-823, GES-1 and 293T: human gastric cell lines; HCT-8 and HT-29: h
acrophage cell lines; hMDM:  human monocyte-derived macrophage cell line; BM
Taken together, these studies indicate that bacteria can control
iRNA expression in order to subvert host defences.
.3. Regulation of host gene expression by bacterial non-coding
NAs
In addition to deregulation of endogenous microRNAs, emerging
ata suggest that bacteria could also produce regulatory RNAs that
ould modulate the host gene expression, as previously shown for
iruses (reviewed in [89]). A typical example of this system is the
. coli OxyS and DsrA ncRNAs which, after ingestion by Caenorhab-
itis elegans,  modulate che-2 and F42G9.6 gene expression, probably
y promoting the degradation of the host transcripts [90]. Recently,
wo studies have investigated bacterial microRNA-like molecules.
irst, an in silico search for bacterial ncRNAs harbouring a sec-
ndary structure that might generate miRNA if processed by the
ost has identiﬁed 68 candidate bacterial RNAs from 28 bacterial
enomes [91]. These putative bacterial miRNAs are predicted to
arget mRNAs involved in 47 different human diseases, including
ancer and diabetes, thus providing a new perspective for bacte-
ial inﬂuence on health and disease. In an independent study, a
re-microRNA was identiﬁed in Mycobacterium marinum, for which
 mature 23 nucleotide-long form was found associated with the
ost RISC complex upon infection (Fig. 2k) [92]. While the abun-
ance of the endogenous pre-microRNA was too low to induce any
etectable effect, their overexpression efﬁciently decreased mRNA
arget expression. This type of bacterial-derived miRNA molecules
ay thus represent a novel class of regulatory factors in the host
athogen crosstalk.
. Long noncoding RNAs at play in response to bacterial
nfection
The involvement of lncRNAs in defence against viruses has been
ell described (reviewed in [8]), and recent publications show that
everal lncRNAs are involved in inﬂammatory response to LPS and
ive bacteria. Among them, LINoCR (for LPS Inducible NonCoding
NA) activates the expression of lysozyme in a chicken macrophage
ell line challenged with LPS, by remodelling the chromatin (Fig. 2l)Please cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
93]. More recently, lncRNA proﬁles in response to infection or LPS
timulation have been analysed in several mammalian cell lines,
nd the mechanism of action for some of these lncRNAs has been
lucidated.sses, favouring their survival and/or proliferation. AGS, SGC7901, MKN28, MKN45,
 colonic cell lines; HeLa: human cervix cell line; J774A.2 and RAW 264.7: murine
urine bone marrow-derived macrophage cell line; mDC: mice dendritic cell line.
In human monocytes, 76 enhancer RNAs (eRNA), 40 canoni-
cal lncRNAs, 65 antisense lncRNAs and 35 regions of bidirectional
transcription are differently expressed upon LPS stimulation, [94].
Knockdowns of IL1-eRNA and of a region of bidirectional tran-
scription (IL1ˇ-RBT46) attenuate LPS-induced mRNA transcription
and release of proinﬂammatory mediators, highlighting their impli-
cation in the inﬂammatory response. One lncRNA, lnc-IL7R, has
been well characterized: this lncRNA is a negative regulator
of proinﬂammatory mediators such as IL-8, IL-6, E-selectin and
VCAM-1, by maintaining a repressive chromatin mark, trimethyla-
tion of histone H3 at lysine 27 (H3K27me3) at their gene promoters
[95]. In contrast, NeST lncRNA expressed in mice CD4+/CD8+ T
cells promotes IFN- production by methylating lysine 4 of his-
tone H3 – a mark of active transcription – at the IFN- locus [96].
In mouse bone-marrow derived macrophages (BMDMs), 27 lncR-
NAs are differentially expressed upon LPS stimulation, and their
de-regulation is associated with histone trimethylation or acetyla-
tion of neighbouring genes, suggesting a possible regulatory role in
innate-immune response [97]. In HeLa cells infected by Salmonella,
a variation of 44% of total lncRNAs has been monitored, leading the
authors to propose that lncRNAs could be used as sensitive markers
for pathogen activity in the early infection phase [98]. Last, HOTAIR,
a lncRNA ﬁrst shown to participate in the transcriptional repres-
sion of HOX genes [99], is also a positive regulator of inﬂammation
[100]. Indeed, HOTAIR up-regulation in mice cardiomyocytes after
LPS-induced sepsis induces TNF- production by promoting phos-
phorylation of p65 protein and NF-B activation.
A subtype of lncRNAs named lincRNAs (long intergenic non-
coding RNAs), which are expressed from intergenic regions, have
also been studied. In bone marrow dendritic cells, LPS stimula-
tion induces the expression of about 20 lincRNAs, most of them
being dependent of NF-B. Among them, lincRNA-Cox2 is the most
expressed [101]. This lincRNA is also up-regulated in mouse bone-
marrow derived macrophages upon stimulation by TLR ligands, as
well as by L. monocytogenes [102], and modulates the expression of
many genes involved in inﬂammation. More precisely, the authors
could identify that lincRNA-Cox2 forms a complex with hnRNP-A/B
and −A2/B1, two  nuclear RNA binding proteins, and thereby repress
the transcription of immune genes [102].
LncRNAs can also arise from the expression of pseudogenes.RNAs and long noncoding RNAs in the host-bacterial pathogen
cdb.2016.06.016
Among them Lethe, which is induced by NF-B upon TNF- stim-
ulation, was  recently found to contribute to a negative feedback
regulation of this pathway, by sequestering the RelA/p65 subunit
and thus inactivating its DNA binding activity [103] (Fig. 2m). The
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ctive regulation of pseudogene lncRNA expression can thus con-
titute a means to control inﬂammatory signalling.
The above-reported studies highlight the involvement of lncR-
As in inﬂammatory response. Even though some of them
ere performed using live bacteria, whether bacterial pathogens
an subvert lncRNA-mediated regulation remains to be further
xplored. A ﬁrst hint of bacterial subversion of lncRNA was  obtained
n macrophages infected by BCG, showing that 11 lncRNAs were less
xpressed during a challenge with live bacteria compared to heat
nactivated bacteria [104].
. Conclusion
The major property of ncRNAs is certainly their ability to
egulate several targets by speciﬁc base-pairing; thereby, they con-
titute a potent tool allowing cells to tune the expression of a whole
egulon with one simple mechanism. As described above, ncRNAs
an affect all steps in the gene expression process. When affecting
he translation and stability of mature mRNAs, their action takes
lace at a downstream step in the pathway; as a consequence, their
ffects are more immediate and ﬂexible than those of transcrip-
ional regulators. Regulation by ncRNAs thus provide a diversity
f responses by the host cell during the early stages of bacterial
nfection, when cells readjust promptly their gene expression pro-
ramme  to face damage and organize immune defences. Given the
arious microRNAs and lncRNAs that are differentially regulated in
esponse to bacterial pathogens, in diverse cell types and tissues,
hey constitute a reservoir of gene expression that can ﬁne-tune an
mpressive number of putative targets.
In addition to their direct regulatory activity on target gene
xpression, lncRNA and miRNA may  also regulate each other;Please cite this article in press as: M.  Duval, et al., Mammalian micro
crosstalk, Semin Cell Dev Biol (2016), http://dx.doi.org/10.1016/j.sem
ncRNAs can act as miRNA sponges, in a process described as “com-
etitive endogenous RNA” (ceRNA, reviewed in [105]). Reciprocally,
iRNAs may  indirectly inﬂuence gene expression by targeting
ncRNAs [104]. Thus, a complex regulatory network is at play in the
messenger RNAs
lncRNAs miRNAs
regulatory RNAs
miR-like RNAs
messenger RNAs
secreted 
proteins
?
?
host response, immunity
bacterial adaptation, 
subversion, survival
pathogen
host cell
ig. 4. The coding/non-coding RNA interplay in host-pathogen crosstalk.
uring host-pathogen interaction, RNA is a key regulatory molecule allowing bac-
erial adaptation, subversion and survival, as well as host response and immunity.
ukaryotic ncRNAs are able to cross-regulate themselves, and could even regulate
acterial genes. In addition, bacterial regulatory RNAs as well as secreted effectors
re  able to modulate the host transcriptome. Thus, a complex RNA network is at
lay  in the host-pathogen crosstalk. PRESS
mental Biology xxx (2016) xxx–xxx 7
host cell to tightly modulate gene expression. This type of inter-
play might be involved in host response against bacterial infection,
as recently shown for cancer [106]. Given the arising data on the
ability of regulatory RNAs produced by pathogens to regulate host
gene expression and also the possible regulatory function of cel-
lular RNAs on the pathogen, the role of RNA in the host-pathogen
crosstalk might be even more sophisticated than previously antic-
ipated (Fig. 4).
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